Schizophrenia Research
Volume 89, Issue 1 , Pages 91-100, January 2007

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?☆

The Zucker Hillside Hospital, North Shore–Long Island Jewish Health System, Glen Oaks, NY, United States

Albert Einstein College of Medicine, Bronx, NY, United States

Received 11 July 2006; received in revised form 13 August 2006; accepted 16 August 2006. published online 30 October 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Grant support: The Zucker Hillside Hospital Mental Advanced Center for Intervention and Services Research for the Study of Schizophrenia (MH074543-01) from the National Institute of Mental Health, Bethesda, Md.

PII: S0920-9964(06)00364-1

doi:10.1016/j.schres.2006.08.017

Schizophrenia Research
Volume 89, Issue 1 , Pages 91-100, January 2007

Article Tools

* Image Usage & Resolution